APOE and Alzheimer disease: We believe that recent changes in scientific knowledge and AD health strategies created a demand for a fast, cost-effective and accurate method for detection of APOE ε4 carriers within the laboratory routine in a high-throughput and automated manner, without all the logistic problems of APOE genotyping by PCR.